2020
DOI: 10.1186/s12933-020-01117-1
|View full text |Cite
|
Sign up to set email alerts
|

Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study

Abstract: Background High N-terminal pro-brain-type natriuretic peptide levels have been associated with a lower risk of type 2 diabetes mellitus (T2D). However, less is known about other cardiac stress biomarkers in this context. Here we evaluated the association of mid-regional pro-atrial natriuretic peptide (MR-proANP), C-terminal pro-arginine vasopressin (copeptin), C-terminal pro-endothelin-1 (CT-proET-1) and mid-regional pro-adrenomedullin (MR-proADM) with incident T2D and changes in glucose metabo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

6
1

Authors

Journals

citations
Cited by 12 publications
(20 citation statements)
references
References 47 publications
0
20
0
Order By: Relevance
“…This finding was substantiated in a subsequent analysis. High plasma concentrations of mid-regional pro atrial natriuretic peptide (MR-proANP), another peptide from the natriuretic peptide system, were also associated with a lower risk of incident DM and insulin resistance [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…This finding was substantiated in a subsequent analysis. High plasma concentrations of mid-regional pro atrial natriuretic peptide (MR-proANP), another peptide from the natriuretic peptide system, were also associated with a lower risk of incident DM and insulin resistance [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…Glucose levels were measured in serum using a hexokinase method (GLUFlex, Dade Behring) at baseline and an enzymatic colorimetric method on a Dimension Vista 1500 instrument (Siemens) or the GLUC3 assay on a Cobas c702 instrument (Roche Diagnostics, Mannheim, Germany) at follow-up. 29 Hemoglobin A1c (HbA1c) was measured in hemolyzed whole blood using the cation-exchange high performance liquid chromatographic, photometric VARIANT II TURBO HbA1c Kit – 2.0 assay on a VARIANT II TURBO Hemoglobin Testing System (Bio-Rad Laboratories Inc, Hercules, USA). Insulin was measured by an electrochemiluminescence immunoassay on a Cobas e602 instrument (Roche) in KORA F4.…”
Section: Methodsmentioning
confidence: 99%
“…The following potential confounder variables were assessed at baseline and used for adjustment: sex, age, BMI, years of education (numerical), ever-smoking status (yes/no), leisure time physical activity (active/inactive [ 26 ]), parental diabetes (yes/no) and hypertension (yes/no, defined as >140/90 mmHg). In addition, baseline laboratory measures of total triacylglycerols (mmol/l), the ratio of total cholesterol to HDL-cholesterol (HDL-C), HOMA-IR and fasting serum glucose (mmol/l) were used as potential confounders [ 26 ]. HOMA-IR was calculated as previously described [ 26 ].…”
Section: Methodsmentioning
confidence: 99%
“…In addition, baseline laboratory measures of total triacylglycerols (mmol/l), the ratio of total cholesterol to HDL-cholesterol (HDL-C), HOMA-IR and fasting serum glucose (mmol/l) were used as potential confounders [ 26 ]. HOMA-IR was calculated as previously described [ 26 ].…”
Section: Methodsmentioning
confidence: 99%